Jazz Pharmaceuticals plc (JAZZ) /
The debt of Jazz Pharmaceuticals plc over the past 10 years
Chart Jazz Pharmaceuticals plc: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Jazz Pharmaceuticals plc had liquid cash of $2.44B and total debt of $5.36B: net debt of $2.92B. It had more liquid cash than debt at 1 of the 10 year-ends shown. Total debt was highest at the end of fiscal 2024 ($6.11B) and lowest at the end of fiscal 2017 ($1.58B).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.44B* | $5.36B | -$2.92B |
| 2024ended Dec 31, 2024 | $2.99B* | $6.11B | -$3.12B |
| 2023ended Dec 31, 2023 | $1.63B* | $5.71B | -$4.09B |
| 2022ended Dec 31, 2022 | $881.48M* | $5.72B | -$4.84B |
| 2021ended Dec 31, 2021 | $591.45M | $6.05B | -$5.46B |
| 2020ended Dec 31, 2020 | $2.13B* | $2.09B | $37.93M |
| 2019ended Dec 31, 2019 | $1.08B* | $1.61B | -$529.91M |
| 2018ended Dec 31, 2018 | $824.62M* | $1.6B | -$771.79M |
| 2017ended Dec 31, 2017 | $601.03M* | $1.58B | -$980M |
| 2016ended Dec 31, 2016 | $425.96M* | $2.03B | -$1.6B |
Fiscal years as Jazz Pharmaceuticals plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Jazz Pharmaceuticals plc
- The revenue of Jazz Pharmaceuticals plc
- The profitability of Jazz Pharmaceuticals plc
- The cash flow of Jazz Pharmaceuticals plc
- All of Jazz Pharmaceuticals plc's financials, charted
Companies of a similar size
- RBCRBC BEARINGS INCORPORATED
- NBIXNEUROCRINE BIOSCIENCES INC
- SWKSTANLEY BLACK & DECKER, INC.
- PFGCPerformance Food Group Company
- ULSUL Solutions Inc.
Not investment advice. This page shows what Jazz Pharmaceuticals plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.